Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Athira Pharma Inc
(NQ:
ATHA
)
0.4439
-0.0060 (-1.33%)
Streaming Delayed Price
Updated: 12:14 PM EDT, Oct 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Athira Pharma Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
NASDAQ:ATHA Shareholder Notice: Update in Lawsuit Against Athira Pharma, Inc.
January 18, 2023
San Diego, CA -- (SBWIRE) -- 01/18/2023 -- The Shareholders Foundation announced an update in the lawsuit that was filed on behalf of certain investors in Athira Pharma, Inc. (NASDAQ:ATHA).
Via
SBWire
Athira Pharma Provides 2023 Pipeline Outlook
January 05, 2023
From
Athira Pharma, Inc.
Via
GlobeNewswire
4 Penny Stocks Insiders Are Buying: Athira Pharma, Great Elm Group And More
January 03, 2023
US stocks recorded losses for 2022. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's...
Via
Benzinga
Athira Pharma Announces Publication of Fosgonimeton Preclinical Results in Neurotherapeutics
December 21, 2022
Data demonstrate fosgonimeton enhances the HGF/MET system, promoting neuroprotective, neurotrophic and procognitive effects in multiple cell and animal models
From
Athira Pharma, Inc.
Via
GlobeNewswire
Athira Outlines Possible Comeback For Alzheimer's Candidate
September 06, 2022
Via
Benzinga
Athira Pharma: Q2 Earnings Insights
August 15, 2022
Athira Pharma (NASDAQ:ATHA) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
4 Analysts Have This to Say About Athira Pharma
June 23, 2022
Analysts have provided the following ratings for Athira Pharma (NASDAQ:ATHA) within the last quarter:
Via
Benzinga
Beachbody, Athira Pharma And This Penny Stock Insiders Are Aggressively Buying
December 07, 2022
The Dow Jones closed lower by nearly 350 points on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
Athira Pharma Presents Preclinical Data Supporting Therapeutic Potential of ATH-1105 in ALS at the 33rd International Symposium on ALS/MND
December 05, 2022
From
Athira Pharma, Inc.
Via
GlobeNewswire
Athira Pharma to Host Virtual R&D Event on December 7, 2022, from 2:00 –3:30 pm Eastern time
December 01, 2022
Highlighting consistent preclinical and clinical data demonstrating the potential of HGF/MET as a neuroprotective and disease-modifying approach to treat neurodegenerative diseases
From
Athira Pharma, Inc.
Via
GlobeNewswire
Athira Pharma Highlights Therapeutic Potential of Fosgonimeton in Presentation of Additional Biomarker Data in Mild-to-Moderate Alzheimer’s Disease Patients from ACT-AD Phase 2 Study at CTAD Conference
November 29, 2022
From
Athira Pharma, Inc.
Via
GlobeNewswire
Athira Pharma to Present Preclinical Data Highlighting Therapeutic Potential of ATH-1105 in ALS at the 33rd International Symposium on ALS/MND
November 28, 2022
HGF/MET small molecule positive modulator provides neuroprotection and improves motor and nerve function in a TDP-43 mouse model of ALS
From
Athira Pharma, Inc.
Via
GlobeNewswire
Athira Pharma to Present Additional Biomarker Data from ACT-AD Phase 2 Study of Fosgonimeton at the 2022 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
November 21, 2022
Fosgonimeton demonstrates improvement on diverse biomarkers of neurodegeneration
From
Athira Pharma, Inc.
Via
GlobeNewswire
Around $4 Million Bet On Lesaka Technologies? Check Out These 4 Penny Stocks Insiders Are Buying
November 18, 2022
US crude oil futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
Athira Pharma Presents Preclinical Data Supporting Therapeutic Potential of HGF/MET Platform at Neuroscience 2022 Conference
November 16, 2022
From
Athira Pharma, Inc.
Via
GlobeNewswire
Athira Pharma Reports Third Quarter 2022 Financial Results and Recent Clinical and Corporate Updates
November 10, 2022
From
Athira Pharma, Inc.
Via
GlobeNewswire
Athira Pharma to Present at Stifel 2022 Healthcare Conference
November 09, 2022
From
Athira Pharma, Inc.
Via
GlobeNewswire
Athira Pharma to Present Preclinical Data Highlighting Therapeutic Potential of HGF/MET Platform in Neurodegenerative Disorders at Neuroscience 2022 Conference
November 07, 2022
Data supports neuroprotective and disease modifying potential in models of Parkinson’s disease and diabetic neuropathy
From
Athira Pharma, Inc.
Via
GlobeNewswire
Athira Pharma Advances Phase 2/3 LIFT-AD Clinical Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Patients Following Independent, Unblinded Interim Analysis
October 17, 2022
From
Athira Pharma, Inc.
Via
GlobeNewswire
The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study
July 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022
July 07, 2022
Upgrades
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2022
June 23, 2022
Upgrades
Via
Benzinga
10 Biggest Price Target Changes For Thursday: Alcoa, Travelers And More
June 23, 2022
Morgan Stanley cut Westinghouse Air Brake Technologies Corporation (NYSE: WAB) price target from $113 to $94. Westinghouse Air Brake Technologies shares fell 1.7% to $82.36 in pre-market trading.
Via
Benzinga
76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More
June 23, 2022
Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.
Via
Benzinga
Dow Jumps 150 Points; Ocean Bio-Chem Shares Spike Higher
June 22, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 150 points on Wednesday.
Via
Benzinga
Stocks Quietly Higher as Market Attempts to Extend Rally
June 22, 2022
Stocks are modestly higher at midday.
Via
Talk Markets
U.S. Stocks Turn Higher; Athira Pharma Shares Plummet
June 22, 2022
U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining around 30 points on Wednesday.
Via
Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
June 22, 2022
Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares jumped 116.6% to $12.82 after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.
Via
Benzinga
Exela Technologies (XELA) Stock Soars After Securing $136 Million Contract
June 22, 2022
Exela Technologies (XELA) stock is taking off on Wednesday after gaining a new $136 million customer contract that lasts for three years.
Via
InvestorPlace
Athira Pharma (ATHA) Stock Plunges 65% on Disappointing Drug Trial Results
June 22, 2022
Athira Pharma (ATHA) stock is plummeting on Wednesday following the outcome of a Phase 2 clinical trial of fosgonimeton.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.